Emphasis on Component (Hardware, Services, and Connectivity); Applications (Connected Medical Devices, Remote Patient Monitoring, AR/VR, Asset tracking for medical devices, and Connected Ambulance); End Users (Healthcare Providers, Healthcare Payers, and Other End Users)
Adoption of 5G technology in Healthcare Market is expected to registering a CAGR of around 75% during the forecast period (2021-2027). 5G, the fifth generation of cellular wireless technology, has the potential to provide massive connection power and fast speeds that can help transform healthcare delivery. 5G can impact the Internet of Medical Things (IoMT). Also, it will assist in enabling medical innovations by utilizing augmented reality, virtual reality, artificial intelligence (AI), remote medical learning, remote patient monitoring, and much more. Nowadays, it is necessary to get access to the near real-time data, as well as to make split-second decisions in healthcare environments, and 5G will provide benefits to this sector in the forecast period. The implementation of 5G in healthcare will lead to better communications with high efficiencies, faster diagnostics at lightning speeds, transfers of massive files, images, and other content.
Telemedicine (5G & Healthcare)
Insights Presented in the Report
“Amongst Component, Hardware segment hold the major share.”
Based on Component, the market is fragmented into Hardware, Services, and Connectivity. The Hardware segment dominated the market in 2020 and is expected to grow at lucrative growth owing to the need for frequent up-gradation or replacement to make optimal use of the latest software available in the market. Moreover, the rising adoption of new technologies in healthcare and their high implementation drives the demand for hardware. “Amongst Applications, Connected Medical Devices segment holds the major share.”
Based on Application, the market is fragmented into Connected Medical Devices, Remote Patient Monitoring, AR/VR, Asset tracking for medical devices, and Connected Ambulance. The Connected Medical Devices segment dominated the market in 2020 owing to the growing inclination towards home healthcare and growth in the telehealth market. According to the renowned Irish-based multinational professional services company, 65% of consumers and 86% of doctors agree that wearables increase patients’ engagement with their health. This engagement is expected to decrease hospital costs by 16% over the next five years.
“Amongst End Users, Healthcare Service Providers segment holds the major share.”
Based on End Users, the market is fragmented into Healthcare Service Providers, Healthcare Payers, and Other End Users. The Healthcare Service Providers segment dominated the market in 2020 and is expected to grow at lucrative growth during the forecasted period owing to the rising need for an efficient healthcare system, growing patient volume, and an increasing number of hospitals and ambulatory care centers. Moreover, the growth in telehealth, rising adoption of 5G-enabled wearable medical devices, and the rising demand for better technologies that assist in the easy transfer of large data files also drive the market growth.
“Asia-Pacific region signifies one of the largest markets for 5G in Healthcare market.”
For a better understanding of the market adoption of 5G in healthcare, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. Asia-Pacific is expected to dominate the 5G in the healthcare market on account of the presence of a smaller number of vendors. In addition, the significant adoption of advanced technologies, increasing number of IoT-enabled medical devices, continuously enhancing network connectivity, and government initiatives for IoT also drive the market growth in the region. Some of the major players operating in the market include AT&T, Verizon, China Mobile Limited, T-Mobile, Ericsson, Telit, Telus, Vodafone, Nokia, and Samsung. Several M&As along with partnerships have been undertaken by these players to boost their presence in different regions.
Reasons to buy this report:
Customization Options:
The 5G in Healthcare market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
1. Market Introduction
2. Research Methodology Or Assumption
3. Market Synopsis
4. Executive Summary
5. Global 5g In Healthcare Market Covid-19 Impact
6. Global 5g In Healthcare Market Revenue (usd Bn), 2019-2027f
7. Market Insights By Component
8. Market Insights By Application
9. Market Insights By End Users
10. Market Insights By Region
11. G In Healthcare Market Dynamics
12. G In Healthcare Market Opportunities
13. G In Healthcare Market Trends
14. Legal & Regulatory Framework
15. Demand And Supply Side Analysis
16. Value Chain Analysis
17. Competitive Scenario
18. Company Profiled
19. Disclaimer
Analyzing the historical market, estimation of the current market, and forecasting the future market of the Global 5G in Healthcare market were the three major steps undertaken to create and analyze the adoption of 5G in Healthcare for major application including Connected Medical Devices, Remote Patient Monitoring, AR/VR, Asset tracking for medical devices, and Connected Ambulance. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the 5G in Healthcare sector. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecast the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments the industry pertains to. Detailed methodology is explained below:
Analysis of Historical Market Size
Step 1: In-Depth Study of Secondary Sources:
The detailed secondary study was conducted to obtain the historical market size of the 5G in Healthcare through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.
Step 2: Market Segmentation:
After obtaining the historical market size of the 5G in Healthcare market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments for major regions. Major segments included in the report are Component, Application, End Users, and Region/Country. Further country-level analyses were conducted to evaluate the overall adoption of 5G technology in Healthcare in major region.
Step 3: Factor Analysis:
After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of 5G in Healthcare. Further, we conducted factor analysis using dependent and independent variables such as the rising adoption of IoT in healthcare sector and growing patient data.
Current Market Size Estimate & Forecast
Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the 5G in Healthcare Market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.
Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down approach was applied to arrive at the market forecast to 2027 for different segments and subsegments across the major regions. The research methodology adopted to estimate the market size encompasses:
Market Size and Share Validation
Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, and Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.
Split of Primary Participants in Different Regions
Market Engineering
Data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers of each segment and sub-segment of the 5G in Healthcare market. Data was split into several segments & sub-segments post studying various parameters and trends in the areas of Component, Application, End Users, and Region/Country of the 5G in Healthcare market.
Main Objective of the 5G in Healthcare Market Study
The current & future market trends of 5G in Healthcare were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments from the qualitative and quantitative analysis performed in the study. Current and future market trends were determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit as a first-mover advantage. Other quantitative goals of the studies include:
Customers who bought this item also bought
Antibiotic Resistance Market: Current Analysis and Forecast (2024-2032)
Emphasis on Disease Type (Urinary Tract Infections, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections, And Others); Pathogen Type (Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae, and Others); Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, and Others); and Region/Country
October 8, 2024
